Your privacy choices

We use analytics to improve Pollar and, with your consent, the Meta pixel to measure sign-ups and purchases that come from our ads. You can change this anytime in Settings.

Privacy policy
Pollar
HomeAskLiveBriefSoundsFilmsSearchMapMarketsNotificationsFor You
ThreadsMarkets
NewsroomSupport Pollar
Privacy
Reader-supported

Free to read, and staying that way

Members read the brief without a sponsor. Membership keeps Pollar independent.

from$29.99/yr

Support Pollar
Membership

Members don't see this panel.

  • Supporter$29.99/yr
  • Founder$69.99/yr
Support Pollar

Today’s Brief

Surgeons remove a papal lung lobe

Trump tests Ukraine truce as missiles hit Kyiv and Houthis menace oil routes

The day’s hardest news came from energy systems, some bombed, some hacked, some traded for political relief. War, regulation and technology all pointed to the same frailty: modern states depend on pipes, grids, code and trust that fail noisily when pressure rises.

Read the Brief

Live now

All live coverage
  • Russian drone strike on Lutsk

    Death toll reaches 6 with 12 injured after Russian drone strike hits Lutsk, as rescue teams clear rubble.

  • Pope Leo XIV undergoes lung surgery

    Walks and eats following a quiet night, showing positive recovery signs after the surgery that confirmed his lung cancer diagnosis.

  • SpaceX limits Starlink in Ukraine

    SpaceX caps speeds on Starlink military terminals, causing outages that disrupt Ukrainian drone missions.

In the spotlight

All threads

World · Updated 4m ago

The Middle East after Gaza

Shipping losses and Houthi strikes on Saudi energy sites deepen existing crises, with no new sanctions package, accord change or Israel-Iran confrontation.

ContactPublisher and newsroom
HomeBriefThreadsAsk
Categories
Business·1h ago

NRW government opposes BASF takeover bid for Evonik, RAG foundation stays silent

Economy minister Mona Neubaur told the state parliament on Wednesday, 14 October, that the NRW government is against the takeover. The RAG foundation, which holds about 44 percent of Evonik, has not yet set out its position.

The state government draws a line

On Wednesday, 14 October, NRW economy minister Mona Neubaur (Greens) told the state parliament that the state government opposes BASF's takeover of Evonik, the Essen-based chemicals group. She said Evonik is an important part of the state's energy location and argued that research, development and the company headquarters should stay in North Rhine-Westphalia, particularly as the chemical industry faces structural challenges. Labour minister Karl-Josef Laumann (CDU) added that he wants an independent Evonik to remain in NRW, pointing to the group's good wages and its social partnership. Neubaur also put the RAG foundation on notice as the largest shareholder, saying it must keep financing its perpetual liabilities and invest its assets carefully. The foundation has so far not published a clear line on how it will proceed.

In the chamber, Neubaur put the government's position in one line:

We are against this takeover.

— Mona Neubaur

Offer terms and the board's rejection

BASF has offered 22.15 euros per Evonik share, which values the group including debt at just over 14 billion euros, according to the Frankfurter Allgemeine Zeitung (FAZ). Evonik's executive board rejected that first offer straight away, arguing that the price was no basis for talks. Handelsblatt cites around 10 billion euros for the rejected bid, and the reports have not reconciled the two figures. The companies and the RAG foundation had made the offer public at the end of September, and Evonik has since argued for its independence to investors, unions and politicians. According to the FAZ, BASF's board would raise its bid, but only if Evonik signals flexibility and opens its books. A person close to the transaction told the paper that BASF has no plans to close sites and that Evonik's pledge to rule out operational dismissals until 2032 would stay in place, while a merger would still cost jobs. BASF prefers a cash deal, though partial payment in shares is not ruled out.

Key dates in the BASF-Evonik takeover talks
  1. Late September 2026The companies and the RAG foundation make the BASF takeover offer public
  2. Oct 9, 2026The RAG foundation's supervisory body discusses the offer for the first time in Essen
  3. Oct 13, 2026FAZ reports BASF is ready to raise its bid if Evonik opens its books
  4. Oct 14, 2026The NRW government rejects the takeover in the state parliament

Support independent Pollar

Supporter and Founder memberships keep every article free to read, and add offline reading, audio, and a sponsor-free brief.

See membership tiers

Parliament splits along party lines

The SPD requested the Landtag debate, and parliamentary group leader Jochen Ott warned of job losses and of a gradual shift of central functions away from the state. Ott wants binding employment and site guarantees with a lasting horizon, and he said decisions on Evonik must be made from NRW and for NRW.

A takeover of Evonik would be more than an ordinary stock market deal.

— Jochen Ott

If those conditions are not met, Ott said, other routes should be examined, up to a stake for the state in the company. CDU politician Björn Franken replied that the Evonik board had clearly turned the offer down and accused the SPD of scaremongering. He said the premier and the state government had clearly backed Evonik's sites and that BASF is "not the right player in the system". Franken also stressed that the offer remains non-binding.

There is no binding takeover offer so far.

— Björn Franken

The RAG foundation and the NRW premier

The RAG foundation holds nearly 44 percent of Evonik, which makes it by far the largest single shareholder, and a takeover is hard to push through without its consent. The foundation's executive board is chaired by Bernd Tönjes, who also chairs Evonik's supervisory board. The foundation's supervisory body discussed the offer for the first time on Friday, 9 October, in Essen, and afterwards only said it had been briefed by the executive board. NRW premier Hendrik Wüst (CDU) sits on that body, which is led by former NRW premier Armin Laschet (CDU); federal ministers Katherina Reiche (CDU) and Lars Klingbeil (SPD) and IG BCE chief Michael Vassiliadis are also members. Handelsblatt reports, citing people involved, that Wüst is expected to play for time and postpone a decision, while the main shareholder intends to stay out and let the two executive boards negotiate first.

Essen · Düsseldorf · Ludwigshafen
Mona NeubaurKarl-Josef LaumannJochen OttBjörn FrankenHendrik WüstArmin LaschetKatherina ReicheLars KlingbeilMichael Vassiliadis
DüsseldorfArmin LaschetBjörn FrankenEssenHendrik WüstJochen OttKarl-Josef LaumannKatherina Reiche

5 sources

  • Chemie: NRW-Landesregierung lehnt Evonik-Übernahme durch BASF ab
    Handelsblatt·2h ago
  • NRW-Landtag debattiert BASF-Angebot für Chemiekonzern Evonik
    Süddeutsche Zeitung·3h ago
  • NRW-Landtag debattiert BASF-Angebot für Chemiekonzern Evonik
    DIE WELT·3h ago
  • BASF lockt mit Zusagen für Beschäftigte: NRW-Minister lehnen Evonik-Verkauf an BASF ab
    RP Online·4h ago
  • BASF erhöht Druck auf Evonik und signalisiert höheres Gebot
    Frankfurter Allgemeine·22h ago

Get Pollar Weekly

The week in news, every Friday. Free.

Free. Unsubscribe anytime.

Read next
AI-generated text·
Business·5d ago

Evonik rebuffs BASF takeover approach as RAG foundation holds the final word

Evonik has turned down BASF's approach, but the decision rests with the RAG foundation, which holds 44% of Evonik's shares. Trade union IG BCE has raised doubts about the foundation's resolve.

Read article
Business·Sep 28

Evonik rejects BASF takeover offer valuing chemical group at 14 billion euros

Essen-based specialty chemicals maker Evonik has dismissed an acquisition proposal of approximately 22.15 euros per share from Ludwigshafen rival BASF, citing an inadequate valuation.

Read article
Business·Sep 26

BASF approaches specialty chemical rival Evonik over potential takeover offer

German chemicals producer BASF has submitted a non-binding takeover approach for competitor Evonik, valuing the specialty chemicals manufacturer at an enterprise value of approximately 12 billion euros including debt.

Read article
How this text is made